During 1955-1970, researchers established that cancer cells frequently exhibit altered carbohydrate metabolism, with glycolytic flux and enzyme patterns distinguishing tumor tissues from normal tissues. The period emphasized enzyme activity mapping, carbohydrate metabolism in tumor cells, and isotope tracing to elucidate metabolic fates, underpinning the view that energy pathways are reprogrammed in cancer. Methodologies standardized during this era enabled robust cross-tissue comparisons and laid the groundwork for metabolic biomarker development. Historical Significance: The era provided foundational evidence of altered glycolysis and metabolic plasticity in tumors, cementing cancer metabolism as a central research area. These breakthroughs created a lasting framework for interpreting tumor energetics, guiding subsequent investigations into metabolic targets and diagnostic approaches that extend into modern cancer metabolism research.